An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets.
about
Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsHistone-modifying enzymes, histone modifications and histone chaperones in nucleosome assembly: Lessons learned from Rtt109 histone acetyltransferasesA cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylationComputational Analysis and Predictive Cheminformatics Modeling of Small Molecule Inhibitors of Epigenetic ModifiersA powerful yeast-based screening assay for the identification of inhibitors of indoleamine 2,3-dioxygenase.The essential roles of chemistry in high-throughput screening triagePAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.Crosstalk between epigenetic readers regulates the MOZ/MORF HAT complexes.Chromatin modifiers and the promise of epigenetic therapy in acute leukemiaChemical Biology for Investigating Epigenetic Functions of Lysine Acetyltransferases (KATs).Expression of the MOZ-TIF2 oncoprotein in mice represses senescenceAssay interference and off-target liabilities of reported histone acetyltransferase inhibitors.Uncovering a novel pathway for p16 silencing: Therapeutic implications for lung cancer.Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations.New KAT6 inhibitors induce senescence and arrest cancer growth
P2860
Q26781745-82999FE5-04E3-4E06-8C5A-1E53CEDB0F32Q27003952-979AA016-CFC3-45DF-B2D1-A12276A9CB7BQ28535237-2587BF60-7971-43DB-B7D6-E1524F1837AEQ28554035-00553469-1258-46EC-B94E-79DA721C6FE4Q34335219-99CA1716-FE07-4866-8CF1-B6F183708917Q34435458-4020D3B2-83DE-406D-82B4-8255C14419C5Q34460371-4D03FC2D-4F6F-4FCE-AC7F-123B6B3E8100Q35634908-8E9B6A2A-4489-4816-9602-442433CFA1C5Q37655824-724AF01E-8FC7-416E-8FCF-AFDF6ED0DC0AQ38194444-BB813D9D-3BE3-43F7-9C22-EC654551304AQ38645627-E960E389-A1DB-4778-92EB-C445AC5C7112Q39833707-8A82E77E-6BD3-4A4F-AAFB-C86A38AAAB1CQ47153340-A4B649CD-383D-4F91-8033-D61DC00DB201Q47618947-33CDFF07-8D89-445D-8C74-1DBDF1600BD1Q48185720-1882B93E-381D-4C56-9F60-BA6CDDBFEE35Q58700722-48A2AB62-8269-4886-A470-A676632A8C78
P2860
An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
An efficient high-throughput s ...... ss of epigenetic drug targets.
@ast
An efficient high-throughput s ...... ss of epigenetic drug targets.
@en
An efficient high-throughput s ...... ss of epigenetic drug targets.
@nl
type
label
An efficient high-throughput s ...... ss of epigenetic drug targets.
@ast
An efficient high-throughput s ...... ss of epigenetic drug targets.
@en
An efficient high-throughput s ...... ss of epigenetic drug targets.
@nl
prefLabel
An efficient high-throughput s ...... ss of epigenetic drug targets.
@ast
An efficient high-throughput s ...... ss of epigenetic drug targets.
@en
An efficient high-throughput s ...... ss of epigenetic drug targets.
@nl
P2093
P2860
P356
P1476
An efficient high-throughput s ...... ss of epigenetic drug targets.
@en
P2093
Brendon J Monahan
George Nikolakopoulos
Hendrik Falk
Ian P Street
Joanne L Alcindor
John D Bentley
John P Parisot
Jonathan B Baell
Karen J Loft
P2860
P304
P356
10.1177/1087057111421631
P577
2011-11-14T00:00:00Z